semaglutide barcelona Spain April 30 2025 Stock Stock Photo 2620647151 SUSTAIN 10: Efficacy and Safety

That conversation matters because it reflects something millions of people on GLP-1 medications are quietly experiencing

In addition, semaglutide was associated with a significant 26% reduction in major adverse cardiovascular events compared to placebo in a preapproval cardiovascular outcomes trial (CVOT)

Your delivery will be timely, following a thorough assessment by our medical team and the issuance of your prescription, typically within 5 to 7 days

While initially developed for type 2 diabetes, the FDA has approved specific formulations of semaglutide for chronic weight management in adults and adolescents without diabetes who meet certain criteria